NCT02755428 - Subretinal Transplantation of Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2018

Primary Completion Date

January 31, 2019

Study Completion Date

December 31, 2020

Conditions

Dry Age-related Macular Degeneration

Interventions

BIOLOGICAL

retinal pigment epithelium transplantation

Transplant retinal pigment epithelium derived from human embryonic stem cells into subretinal space of patients with dry age-related macular degeneration(dry AMD).

Trial Locations (1)

100730

RECRUITING

Beijing Tongren Hospitol,Capital Medical University, Beijing